01 1Hubei Haosun Pharmaceutical Co., Ltd.
01 1DESVENLAFAXINE SUCCINATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-12-24
Pay. Date : 2022-09-27
DMF Number : 37237
Submission : 2022-07-04
Status : Active
Type : II
20
Hubei Haosun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding US DMF Number 37237.
Remarkably, this DMF maintains an Active status since its submission on July 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 24, 2022, and payment made on September 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
